{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:23:20Z","timestamp":1759332200743},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:00:00Z","timestamp":1394755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Targ Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11523-014-0312-2","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T20:16:51Z","timestamp":1394655411000},"page":"381-388","source":"Crossref","is-referenced-by-count":26,"title":["Insufficiency of peripheral blood as a substitute tissue for detecting EGFR mutations in lung cancer: a meta-analysis"],"prefix":"10.1007","volume":"9","author":[{"given":"Zhijun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"key":"312_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadh D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63:11\u201330","journal-title":"CA Cancer J Clin"},{"key":"312_CR2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","volume":"10","author":"W Pao","year":"2010","unstructured":"Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760\u2013774","journal-title":"Nat Rev Cancer"},{"key":"312_CR3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD et al (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83:584\u2013594","journal-title":"Mayo Clin Proc"},{"key":"312_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92\u201398","journal-title":"N Engl J Med"},{"key":"312_CR5","doi-asserted-by":"crossref","unstructured":"Scagliotti GV, Selvaggi G, Novello S, et al. The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res 2004;10:4227\u00a0s-4232s.","DOI":"10.1158\/1078-0432.CCR-040007"},{"key":"312_CR6","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0959-8049(96)00243-2","volume":"32A","author":"S Fujino","year":"1996","unstructured":"Fujino S, Enokibori T, Tezuka N et al (1996) A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. Eur J Cancer 32A:2070\u20132074","journal-title":"Eur J Cancer"},{"key":"312_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","volume":"353","author":"FA Shepherd","year":"2005","unstructured":"Shepherd FA, Rodrigues Pereira J, Ciuleanu T et al (2005) Erlotinib in previously treated non-small cell lung cancer. N Engl J Med 353:123\u2013132","journal-title":"N Engl J Med"},{"key":"312_CR8","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.1200\/JCO.2005.02.7078","volume":"23","author":"DW Bell","year":"2005","unstructured":"Bell DW, Lynch TJ, Haserlat SM et al (2005) Epidermal growth factor receptor mutations and gene amplification in non-small cell lung cancer: molecular analysis of the IDEAL\/INTACT gefitinib trials. J Clin Oncol 23:8081\u20138092","journal-title":"J Clin Oncol"},{"key":"312_CR9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/annonc\/mdt012","volume":"24","author":"G Chen","year":"2013","unstructured":"Chen G, Feng J, Zhou C et al (2013) Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC). Ann Oncol 24:1615\u20131622","journal-title":"Ann Oncol"},{"key":"312_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R et al (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13:239\u2013246","journal-title":"Lancet Oncol"},{"key":"312_CR11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497\u20131500","journal-title":"Science"},{"key":"312_CR12","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.2007.14.8494","volume":"26","author":"LV Sequist","year":"2008","unstructured":"Sequist LV, Martins RG, Spigel D et al (2008) First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol 26:2442\u20132449","journal-title":"J Clin Oncol"},{"key":"312_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2007.05.017","volume":"58","author":"DB Costa","year":"2007","unstructured":"Costa DB, Kobayashi S, Tenen DG et al (2007) Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers. Lung Cancer 58:95\u2013103","journal-title":"Lung Cancer"},{"key":"312_CR14","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2003.02.006","volume":"21","author":"G Sozzi","year":"2003","unstructured":"Sozzi G, Conte D, Leon M et al (2003) Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21:3902\u20133908","journal-title":"J Clin Oncol"},{"key":"312_CR15","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/ijc.24653","volume":"125","author":"C He","year":"2009","unstructured":"He C, Liu M, Zhou C et al (2009) Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer. Int J Cancer 125:2393\u20132399","journal-title":"Int J Cancer"},{"key":"312_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lungcan.2010.10.014","volume":"73","author":"M Brevet","year":"2011","unstructured":"Brevet M, Johnson ML, Azzoli CG et al (2011) Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitor. Lung Cancer 73:96\u2013102","journal-title":"Lung Cancer"},{"key":"312_CR17","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/JTO.0b013e3181bbf239","volume":"4","author":"PC Mack","year":"2009","unstructured":"Mack PC, Holland WS, Burich RA et al (2009) EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer. J Thorac Oncol 4:1466\u20131472","journal-title":"J Thorac Oncol"},{"key":"312_CR18","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/1078-0432.CCR-08-2622","volume":"15","author":"TK Yung","year":"2009","unstructured":"Yung TK, Chan KC, Mok TS et al (2009) Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res 15:2076\u20132084","journal-title":"Clin Cancer Res"},{"key":"312_CR19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.bjc.6603949","volume":"97","author":"H Kimura","year":"2007","unstructured":"Kimura H, Suminoe M, Kasahara K et al (2007) Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). Br J Cancer 97:778\u2013784","journal-title":"Br J Cancer"},{"key":"312_CR20","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.2008.17.3930","volume":"27","author":"H Bai","year":"2009","unstructured":"Bai H, Mao L, Wang HS et al (2009) Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non\u2013small-cell lung cancer. J Clin Oncol 27:2653\u20132659","journal-title":"J Clin Oncol"},{"key":"312_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12032-012-0328-3","volume":"30","author":"ST Kim","year":"2013","unstructured":"Kim ST, Sung JS, Jo UH et al (2013) Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)? Med Oncol 30:328","journal-title":"Med Oncol"},{"key":"312_CR22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1759-7714.2012.00133.x","volume":"3","author":"Z Huang","year":"2012","unstructured":"Huang Z, Wang ZJ, Bai H et al (2012) The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI. Thoracic Cancer 3:334\u2013340","journal-title":"Thoracic Cancer"},{"key":"312_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000338790","volume":"85","author":"X Zhao","year":"2013","unstructured":"Zhao X, Han RB, Zhao J et al (2013) Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients. Respiration 85:119\u2013125","journal-title":"Respiration"},{"key":"312_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11670-010-0027-6","volume":"22","author":"GH Song","year":"2010","unstructured":"Song GH, Ren J, Zhang LJ et al (2010) Low correspondence of EGFR mutations in tumor tissue and paired serum of non-small-cell lung cancer patients. Chin J Cancer Res 22:27\u201331","journal-title":"Chin J Cancer Res"},{"key":"312_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jclinpath-2012-201194","volume":"66","author":"G Ellison","year":"2013","unstructured":"Ellison G, Zhu G, Moulis A et al (2013) EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol 66:79\u201389","journal-title":"J Clin Pathol"},{"key":"312_CR26","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1177\/147323001103900425","volume":"39","author":"B Jiang","year":"2011","unstructured":"Jiang B, Liu F, Yang L et al (2011) Serum detection of epidermal growth factor receptor gene mutations using mutant-enriched sequencing in Chinese patients with advanced non-small cell lung cancer. J Int Med Res 39:1392\u20131401","journal-title":"J Int Med Res"},{"key":"312_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/COC.0b013e31823a5217","volume":"36","author":"ST Kim","year":"2013","unstructured":"Kim ST, Jung HY, Sung JS et al (2013) Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer? Am J Clin Oncol 36:57\u201363","journal-title":"Am J Clin Oncol"},{"key":"312_CR28","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3892\/or.2012.1987","volume":"28","author":"C Hu","year":"2012","unstructured":"Hu C, Liu X, Chen Y et al (2012) Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis. Oncol Rep 28:1815\u20131821","journal-title":"Oncol Rep"},{"key":"312_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/JTO.0b013e3182307f98","volume":"7","author":"K Goto","year":"2012","unstructured":"Goto K, Ichinose Y, Ohe Y et al (2012) Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin\/paclitaxel in non-small cell lung cancer. J Thorac Oncol 7:115\u2013121","journal-title":"J Thorac Oncol"},{"key":"312_CR30","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-05-2324","volume":"12","author":"H Kimura","year":"2006","unstructured":"Kimura H, Kasahara K, Kawaishi M et al (2006) Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin Cancer Res 12:3915\u20133921","journal-title":"Clin Cancer Res"},{"key":"312_CR31","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1158\/1078-0432.CCR-08-2592","volume":"15","author":"Y Kuang","year":"2009","unstructured":"Kuang Y, Rogers A, Yeap BY et al (2009) Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer. Clin Cancer Res 15:2630\u20132636","journal-title":"Clin Cancer Res"}],"container-title":["Targeted Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-014-0312-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11523-014-0312-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-014-0312-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:01:01Z","timestamp":1565251261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11523-014-0312-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1007\/s11523-014-0312-2","relation":{},"ISSN":["1776-2596","1776-260X"],"issn-type":[{"value":"1776-2596","type":"print"},{"value":"1776-260X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}